Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2632101000168113 | calcium carbonate 160 mg + sodium alginate 500 mg + sodium bicarbonate 267 mg chewable tablet, 12 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2632111000168111 | sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet, 12 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| calcium carbonate 160 mg + sodium alginate 500 mg + sodium bicarbonate 267 mg chewable tablet, 12 tablets (medicinal product pack) | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| calcium carbonate 160 mg + sodium alginate 500 mg + sodium bicarbonate 267 mg chewable tablet, 12 tablets (medicinal product pack) | has MPUU | sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Double Strength Peppermint chewable tablet, 12 | Is a | True | calcium carbonate 160 mg + sodium alginate 500 mg + sodium bicarbonate 267 mg chewable tablet, 12 tablets (medicinal product pack) | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR